These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7291235)

  • 21. Selective opioid receptor antagonist effects upon intake of a high-fat diet in rats.
    Islam AK; Bodnar RJ
    Brain Res; 1990 Feb; 508(2):293-6. PubMed ID: 2155039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute effects of naloxone and naltrexone, but lack of delayed effects, on exploratory behavior in the rat.
    Koek W; Slangen JL
    Psychopharmacology (Berl); 1984; 84(3):383-7. PubMed ID: 6440184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of chronic naltrexone and methadone administration on brain immunoreactive beta-endorphin in the rat.
    Ragavan VV; Wardlaw SL; Kreek MJ; Frantz AG
    Neuroendocrinology; 1983 Oct; 37(4):266-8. PubMed ID: 6314167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased brain size and cellular content in infant rats treated with an opiate antagonist.
    Zagon IS; McLaughlin PJ
    Science; 1983 Sep; 221(4616):1179-80. PubMed ID: 6612331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ingestive behavior following central [D-Ala2, Leu5, Cys6]-enkephalin (DALCE), a short-acting agonist and long-acting antagonist at the delta opioid receptor.
    Arjune D; Bowen WD; Bodnar RJ
    Pharmacol Biochem Behav; 1991 Jun; 39(2):429-36. PubMed ID: 1658817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of opioid receptor subtypes in rat feeding behavior.
    Simone DA; Bodnar RJ; Goldman EJ; Pasternak GW
    Life Sci; 1985 Mar; 36(9):829-33. PubMed ID: 2983173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behaviourally-selective hypophagic effects of naloxone in non-deprived male rats presented with palatable food.
    Tallett AJ; Blundell JE; Rodgers RJ
    Behav Brain Res; 2008 Mar; 187(2):417-27. PubMed ID: 18022706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of drinking in the rat following the administration of opiate antagonists.
    Cooper SJ; Holtzman SG
    Pharmacol Biochem Behav; 1983 Sep; 19(3):505-11. PubMed ID: 6634902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of naloxone and naltrexone on the increased water intake and drinking duration in phenobarbitone-treated rats.
    Cooper SJ; McGivern H
    Psychopharmacology (Berl); 1983; 79(1):25-8. PubMed ID: 6403960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic prevention of mu-opioid receptor (MOR) G-protein coupling in the pontine parabrachial nucleus persistently decreases consumption of standard but not palatable food.
    Ward HG; Simansky KJ
    Psychopharmacology (Berl); 2006 Sep; 187(4):435-46. PubMed ID: 16847679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naloxone blocks that portion of feeding driven by sweet taste in food-restricted rats.
    Levine AS; Weldon DT; Grace M; Cleary JP; Billington CJ
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R248-52. PubMed ID: 7840328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of baclofen and naltrexone, alone and in combination, on the consumption of palatable food in male rats.
    Avena NM; Bocarsly ME; Murray S; Gold MS
    Exp Clin Psychopharmacol; 2014 Oct; 22(5):460-7. PubMed ID: 25069013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the incentive value of food after naltrexone treatment depend on a differential preference for a palatable food in male rats.
    Alvarado-Bañuelos M; Barrios De Tomasi E; Juárez J
    Nutr Neurosci; 2017 Sep; 20(7):416-423. PubMed ID: 28277185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of naloxone and picrotoxin on diazepam- or pentobarbital-induced hyperphagia in nondeprived rats.
    Naruse T; Asami T; Koizumi Y
    Pharmacol Biochem Behav; 1988 Nov; 31(3):709-11. PubMed ID: 3251254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of palatable diet-induced hyperphagia in rats by central injection of a VEGFR kinase inhibitor.
    Branch A; Bobilev A; Negrao NW; Cai H; Shen P
    Behav Brain Res; 2015 Feb; 278():506-13. PubMed ID: 25448434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenalectomy and the anorectic effects of benzodiazepine inverse agonists and opiate antagonists in rats fed a palatable diet.
    Cooper SJ; Kirkham TC
    Physiol Behav; 1987; 40(4):479-82. PubMed ID: 2819908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naltrexone and human eating behavior: a dose-ranging inpatient trial in moderately obese men.
    Maggio CA; Presta E; Bracco EF; Vasselli JR; Kissileff HR; Pfohl DN; Hashim SA
    Brain Res Bull; 1985 Jun; 14(6):657-61. PubMed ID: 3896411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of chronic administration of naltrexone on appetitive behaviors of rats.
    Lang IM; Strahlendorf JC; Strahlendorf HK; Barnes CD
    Prog Clin Biol Res; 1981; 68():197-207. PubMed ID: 7301882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the effects of opiate antagonists on operant and ingestive behavior.
    Sanger DJ; McCarthy PS
    Pharmacol Biochem Behav; 1982 Jun; 16(6):1013-5. PubMed ID: 7111345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of continuous naltrexone infusions on diet preferences are modulated by adaptation to the diets.
    Gosnell BA; Krahn DD
    Physiol Behav; 1992 Feb; 51(2):239-44. PubMed ID: 1313587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.